Back to Insider Trading View Full Company Profile

ESPR

UNKNOWN

Esperion Therapeutics, Inc.

CIK: 0001434868

Sell (70% confidence)

Last activity: 2 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$45.73M

Total Debt $2.07M

Insider Roster (3 total, 3 active)

Insider	Sells	Net Value	Holdings
Koenig Sheldon L. President and CEO	2	-$247K	2,172,699 shares $5.91M
Halladay Benjamin Chief Financial Officer	2	-$44K	713,602 shares $1.93M
Looker Benjamin Chief Legal Officer	3	-$44K	679,348 shares $1.84M

Recent Transactions

SELL Koenig Sheldon L. (President and CEO)

25,578 shares @ $2.72

$70K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Halladay Benjamin (Chief Financial Officer)

6,424 shares @ $2.71

$17K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Looker Benjamin (Chief Legal Officer)

5,708 shares @ $2.70

$15K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Looker Benjamin (General Counsel)

1,689 shares @ $2.88

$5K

Jan 20, 2026

Conviction: | View SEC Filing →

SELL Koenig Sheldon L. (President and CEO)

48,244 shares @ $3.67

$177K

Dec 17, 2025

Conviction: | View SEC Filing →

SELL Halladay Benjamin (Chief Financial Officer)

7,337 shares @ $3.67

$27K

Dec 17, 2025

Conviction: | View SEC Filing →

SELL Looker Benjamin (General Counsel)

6,517 shares @ $3.67

$24K

Dec 17, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.